<DOC>
	<DOC>NCT00476671</DOC>
	<brief_summary>To assess the prevalence and risk factors of neurocognitive impairment and psychiatric comorbidities in HIV infected patients who have undetectable viral load, have been on HAART for at least 1 year and have no history of CNS infection.</brief_summary>
	<brief_title>Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1</brief_title>
	<detailed_description>To understand how to prevent and treat HIV-associated neurocognitive impairment and psychiatric comorbidities in HIV-infected Thai individuals who don't have current AIDS related illness or current and prior central nervous system (CNS) infection, and have been well treated with HAART with undetectable HIV RNA.</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Signed informed consent Evidence of HIV infection (confirmed positive ELISA and documented history of measurable HIV RNA) Age &gt; 18 years old Plasma HIV RNA of &lt; 50 copies/ml within 3 months prior to screening Have been on only NNRTIbased HAART regimen for the entire duration and for at least1 year. Current AIDS defining illnesses Current or history of previous CNS infection. Head injury with loss of consciousness greater than 1 hour Acute illness within 30 days prior to entry that, in the opinion of investigators, would prevent patients from completing the protocol required procedures. Known learning disability including dyslexia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>neuropsychiatric</keyword>
	<keyword>neurocognitive</keyword>
	<keyword>psychiatric</keyword>
	<keyword>HIV related dementia</keyword>
	<keyword>MCMD</keyword>
	<keyword>HIV-1</keyword>
	<keyword>Prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in HIV-1 infected patients with undetectable viral load in the HAART era.</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>